UK markets closed

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7673+0.0331 (+4.51%)
At close: 04:00PM EDT
0.7789 +0.01 (+1.51%)
After hours: 04:43PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
13,996
14,820
17,655
12,241
8,813
Selling general and administrative
24,827
21,912
15,661
11,291
8,898
Total operating expenses
38,823
36,732
33,316
23,532
17,711
Operating income or loss
-38,823
-36,732
-33,316
-23,532
-17,711
Interest expense
-
-
0
10.839
15.673
Total other income/expenses net
-
3,586
-
226.474
110.207
Income before tax
-37,604
-31,967
-33,065
-23,054
-17,548
Income tax expense
576
576
576
0
0
Income from continuing operations
-38,180
-32,543
-33,641
-23,054
-17,548
Net income
-38,180
-32,543
-33,641
-23,054
-17,548
Net income available to common shareholders
-39,332
-33,694
-33,641
-24,505
-17,548
Basic EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Diluted EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Basic average shares
151,295
151,295
146,082
108,599
39,165
Diluted average shares
151,295
151,295
146,082
108,599
39,165